Obeticholic Acid Patent Expiration
Obeticholic Acid is used for treating Primary Biliary Cholangitis (PBC) in adults. It was first introduced by Intercept Pharmaceuticals Inc
Obeticholic Acid Patents
Given below is the list of patents protecting Obeticholic Acid, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ocaliva | US10052337 | Compositions of obeticholic acid and methods of use | Apr 26, 2036 | Intercept Pharms Inc |
| Ocaliva | US10751349 | Compositions of obeticholic acid and methods of use | Apr 26, 2036 | Intercept Pharms Inc |
| Ocaliva | US10758549 | Compositions of obeticholic acid and methods of use | Apr 26, 2036 | Intercept Pharms Inc |
| Ocaliva | US10047117 | Preparation and uses of obeticholic acid | Sep 06, 2033 | Intercept Pharms Inc |
| Ocaliva | US10174073 | Preparation and uses of obeticholic acid | Jun 17, 2033 | Intercept Pharms Inc |
| Ocaliva | US9238673 | Preparation and uses of obeticholic acid | Jun 17, 2033 | Intercept Pharms Inc |
| Ocaliva | USRE48286 | Steroids as agonists for FXR | Feb 21, 2027 | Intercept Pharms Inc |
| Ocaliva | US7138390 | Steroids as agonists for FXR |
Nov 16, 2022
(Expired) | Intercept Pharms Inc |
| Ocaliva | US8058267 | Steroids as agonists for FXR |
Feb 21, 2022
(Expired) | Intercept Pharms Inc |
| Ocaliva | US8377916 | Steroids as agonists for FXR |
Feb 21, 2022
(Expired) | Intercept Pharms Inc |
Obeticholic Acid's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List